Clinical trial
The Study on Effectiveness and Mechanisms of Transcranial Alternating Current Stimulation in Treating Increased Inflammatory Activity Refractory Depression
NCT06812923 is registered in ClinicalTrials.gov with Tianjin Anding Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Study on Effectiveness and Mechanisms of Transcranial Alternating Current Stimulation in Treating Increased Inflammatory Activity Refractory Depression
- Lead sponsor
- Tianjin Anding Hospital
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- January 1, 2025
- Completion date
- December 31, 2028
- Enrollment
- 52 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
inflammation, treatment resistant depression (trd)